References
- Rosamond W, Flegal K, Furie K, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics 2008 Update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-46. Available at: http://circ.ahajournals.org/cgi/content/full/117/4/e25 [Last accessed 20 January 2010]
- Carswell JL, Beard KA, Chevrette MM, et al. Tracking trends in secondary stroke prevention strategies. Ann Pharmacother 2004;38:215-19
- Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases. Bethesda, MD: National Heart, Lung, and Blood Institute, 2006
- Samsa GP, Bian J, Lipscomb J, et al. Epidemiology of recurrent cerebral infarction: a Medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke 1999;30:338-49
- Coull AJ, Rothwell PM. Underestimation of the early risk of recurrent stroke. Stroke 2004;35:1925-9
- Lovett JK, Dennis MS, Sandercock PAG, et al. Very early risk of stroke after a transient ischemic attack. Stroke 2003;34:e138-40
- Coull AJ, Lovett JK, Rothwell PM. Oxford Vascular Study. Population based study of early risk of stroke after transient ischemic attack or minor stroke: implications for public education and organisation of services. BMJ 2004;328:326-8
- Shaya FT, El Khoury AC, Mullins CD, et al. Drug therapy persistence and stroke recurrence. Am J Manag Care 2006;12:313-19
- National Stroke Association. Secondary (Recurrent) Risk. Available at: http://www.stroke.org/site/PageServer?pagename=RECUR [Last accessed 20 January 2010]
- Antithrombotic Trialists’ Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ 2002;324:71-86
- Haynes RB, Montague P, Oliver T, et al. Interventions for helping patients follow prescriptions for medications. Cochrane Database Syst Rev 2000;2:CD000011
- Johnson P, Rosewell M, James MA. How good is the management of vascular risk after stroke, transient ischaemic attack or carotid endarterectomy?. Cerebrovasc Dis 2007;23:156-61
- Wang Y, Wu D, Wang Y, et al. A survey on adherence to secondary ischemic stroke prevention. Neurol Res 2006;28:16-20
- Zusman RM. Clinical and economic implications of atherosclerosis. Manag Care 2000;9:1-4
- Health Insurance Portability and Accountability Act of 1996. Public Law 104-191, 104th Congress. Available at: http://www.cms.hhs.gov/HIPAAGenInfo/Downloads/HIPAALaw.pdf [Last accessed 20 January 2010]
- Tirschwell DL, Longstreth WT Jr. Validating administrative data in stroke research. Stroke 2002;33:2465-70
- Clinical Classifications Software (CCS) for ICD-9-CM. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/ccs/ccs.jsp [Last accessed 20 January 2010]
- Sappok T, Faulstich A, Stuckert E, et al. Adherence with secondary prevention of ischemic stroke: a prospective evaluation. Stroke 2001;32:1884-9
- Hamann GF, Weimar C, Glahn J, et al. German Stroke Data Bank. Adherence to secondary stroke prevention strategies: results from the German Stroke Data Bank. Cerebrovasc Dis 2003;15:282-8
- Hart RG, Benavente O, McBride R, et al. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999;131:492-501
- Albers GW, Easton JD, Sacco RL, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 1998;114:683S-98S
- Levine DA, Safford MM, Allison JJ, et al. Long-term use of secondary stroke prevention therapies among US veterans. 2008 International Stroke Conference, New Orleans, Louisiana, February 20–22, 2008
- Gencheva E, Sloan M, Leurgans S, et al. AAASPS Investigators Attrition and non-compliance in secondary stroke prevention trials. Neuroepidemiology 2004;23:61-6
- Mochari H, Ferris A, Adigopula S, et al. Cardiovascular disease knowledge, medication adherence, and barriers to preventive action in a minority population. Prev Cardiol 2007;10:190-5
- Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation 2000;70:1240-4
- Buckalew LW, Buckalew NM. Survey of the nature and prevalence of patients’ noncompliance and implications for intervention. Psychol Rep 1995;76:315-21